Heparin is a unique marker of progenitors in the glial cell lineage

被引:25
作者
Stringer, SE
Mayer-Proschel, M
Kalyani, A
Rao, M
Gallagher, JT
机构
[1] Paterson Inst Canc Res, Canc Res Campaign, Drug Dev & Imaging Sect, Manchester M20 4BX, Lancs, England
[2] Univ Manchester, Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[4] Univ Utah, Sch Med, Dept Anat & Neurobiol, Salt Lake City, UT 84132 USA
关键词
D O I
10.1074/jbc.274.36.25455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oligodendrocyte-type-2 astrocyte progenitor cells (precursors of oligodendrocytes and type-2 astrocytes) are an excellent system in which to study differentiation as they can be manipulated in vitro. Maintenance of oligodendrocyte-type-2 astrocyte progenitor cells requires basic fibroblast growth factor, a growth factor whose action normally depends on a heparan sulfate coreceptor. Biochemical analysis revealed a most surprising result: that the oligodendrocyte type-2 astrocyte progenitors did not synthesize heparan sulfate, the near ubiquitous N-sulfated cell surface polysaccharide, but the chemically related heparin in a form that was almost completely N- and O-sulfated. The heparin was detected in the pericellular fraction of the cells and the culture medium. In contrast the differentiated glial subpopulations (oligodendrocytes and type-2 astrocytes) synthesized typical heparan sulfate but with distinctive fine structural features for each cell type. Thus heparin is a unique differentiation marker in the glial lineage. Previously heparin has been found only in a subset of mature mast cells called the connective tissue mast cells. Its presence within the developing nervous system on a precise population of progenitors may confer specific and essential recognition properties on those cells in relation to binding soluble growth and/or differentiation factors and the extracellular matrix.
引用
收藏
页码:25455 / 25460
页数:6
相关论文
共 56 条
[1]   Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family [J].
Aikawa, J ;
Esko, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2690-2695
[2]  
ANDERSSON M, 1994, J BIOL CHEM, V269, P926
[3]  
Aschner M, 1998, NEUROTOXICOLOGY, V19, P269
[4]  
Bansal R, 1997, J NEUROSCI RES, V50, P215
[5]   COOPERATION BETWEEN 2 GROWTH-FACTORS PROMOTES EXTENDED SELF-RENEWAL AND INHIBITS DIFFERENTIATION OF OLIGODENDROCYTE TYPE-2 ASTROCYTE (O-2A) PROGENITOR CELLS [J].
BOGLER, O ;
WREN, D ;
BARNETT, SC ;
LAND, H ;
NOBLE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6368-6372
[6]   Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development [J].
Brickman, YG ;
Ford, MD ;
Gallagher, JT ;
Nurcombe, V ;
Bartlett, PF ;
Turnbull, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4350-4359
[7]   Expression of the mouse mastocytoma glucosaminyl N-deacetylase N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate [J].
Cheung, WF ;
Eriksson, I ;
KuscheGullberg, M ;
Lindahl, U ;
Kjellen, L .
BIOCHEMISTRY, 1996, 35 (16) :5250-5256
[8]   DEVELOPMENTAL-CHANGES IN HEPARAN-SULFATE EXPRESSION - INSITU DETECTION WITH MABS [J].
DAVID, G ;
BAI, XM ;
VANDERSCHUEREN, B ;
CASSIMAN, JJ ;
VANDENBERGHE, H .
JOURNAL OF CELL BIOLOGY, 1992, 119 (04) :961-975
[9]   SPECIFICITY STUDIES ON THE HEPARIN LYASES FROM FLAVOBACTERIUM-HEPARINUM [J].
DESAI, UR ;
WANG, HM ;
LINHARDT, RJ .
BIOCHEMISTRY, 1993, 32 (32) :8140-8145
[10]   Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain [J].
Feyzi, E ;
Lustig, F ;
Fager, G ;
Spillmann, D ;
Lindahl, U ;
Salmivirta, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5518-5524